These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14691306)

  • 1. VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model.
    Nakatsu MN; Sainson RC; Pérez-del-Pulgar S; Aoto JN; Aitkenhead M; Taylor KL; Carpenter PM; Hughes CC
    Lab Invest; 2003 Dec; 83(12):1873-85. PubMed ID: 14691306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.
    Amin MA; Volpert OV; Woods JM; Kumar P; Harlow LA; Koch AE
    Circ Res; 2003 Aug; 93(4):321-9. PubMed ID: 12881477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis.
    Giuliani N; Lunghi P; Morandi F; Colla S; Bonomini S; Hojden M; Rizzoli V; Bonati A
    Leukemia; 2004 Mar; 18(3):628-35. PubMed ID: 14737074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory Effect of Vascular Endothelial Growth Factor on Proliferation and Migration of Porcine Trophectoderm Cells and Their Regulation by the Phosphatidylinositol-3-Kinase-AKT and Mitogen-Activated Protein Kinase Cell Signaling Pathways.
    Jeong W; Kim J; Bazer FW; Song G
    Biol Reprod; 2014 Mar; 90(3):50. PubMed ID: 24451985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol inhibits vascular endothelial growth factor-A--induced migration of human umbilical vein endothelial cells.
    Matsunaga N; Shimazawa M; Otsubo K; Hara H
    J Pharmacol Sci; 2008 Jan; 106(1):128-35. PubMed ID: 18187933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
    Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS
    Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R; Inbal A
    Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
    Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
    J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
    Morbidelli L; Pyriochou A; Filippi S; Vasileiadis I; Roussos C; Zhou Z; Loutrari H; Waltenberger J; Stössel A; Giannis A; Ziche M; Papapetropoulos A
    Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R824-32. PubMed ID: 20032260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells.
    Mechtcheriakova D; Schabbauer G; Lucerna M; Clauss M; De Martin R ; Binder BR; Hofer E
    FASEB J; 2001 Jan; 15(1):230-242. PubMed ID: 11149911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling.
    De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A
    Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Raf in vascular protection from distinct apoptotic stimuli.
    Alavi A; Hood JD; Frausto R; Stupack DG; Cheresh DA
    Science; 2003 Jul; 301(5629):94-6. PubMed ID: 12843393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury.
    Lidington EA; Haskard DO; Mason JC
    Blood; 2000 Oct; 96(8):2784-92. PubMed ID: 11023512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways.
    Salameh A; Galvagni F; Bardelli M; Bussolino F; Oliviero S
    Blood; 2005 Nov; 106(10):3423-31. PubMed ID: 16076871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand.
    Min JK; Kim YM; Kim YM; Kim EC; Gho YS; Kang IJ; Lee SY; Kong YY; Kwon YG
    J Biol Chem; 2003 Oct; 278(41):39548-57. PubMed ID: 12893832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases.
    Yao JS; Chen Y; Zhai W; Xu K; Young WL; Yang GY
    Circ Res; 2004 Aug; 95(4):364-71. PubMed ID: 15256478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.